These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27532439)

  • 1. The Impact of Time on Decorporation Efficacy After a "Dirty Bomb" Attack Studied by Simulation.
    Rump A; Stricklin D; Lamkowski A; Eder S; Abend M; Port M
    Drug Res (Stuttg); 2016 Nov; 66(11):607-613. PubMed ID: 27532439
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical management of victims contaminated with radionuclides after a "dirty bomb" attack.
    Rump A; Becker B; Eder S; Lamkowski A; Abend M; Port M
    Mil Med Res; 2018 Aug; 5(1):27. PubMed ID: 30086798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Incorporation of Radionuclides After Wounding by a "Dirty Bomb": The Impact of Time for Decorporation Efficacy and a Model for Cases of Disseminated Fragmentation Wounds.
    Rump A; Stricklin D; Lamkowski A; Eder S; Abend M; Port M
    Adv Wound Care (New Rochelle); 2017 Jan; 6(1):1-9. PubMed ID: 28116223
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL
    Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconsidering Current Decorporation Strategies after Incorporation of Radionuclides.
    Rump A; Stricklin D; Lamkowski A; Eder S; Abend M; Port M
    Health Phys; 2016 Aug; 111(2):204-11. PubMed ID: 27356066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents.
    An DD; Kullgren B; Jarvis EE; Abergel RJ
    Chem Biol Interact; 2017 Apr; 267():80-88. PubMed ID: 27038878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
    Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit-Cost Analysis of Radiocesium Decorporation by a Prussian Blue Treatment and Stockpiling.
    Rump A; Stricklin D; Lamkowski A; Eder S; Port M
    Drug Res (Stuttg); 2018 Feb; 68(2):89-99. PubMed ID: 29036734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
    Taylor DM; Hodgson SA; Stradling N
    Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and clinical management of internal contamination.
    Dainiak N; Albanese J
    J Radiol Prot; 2022 Nov; 42(4):. PubMed ID: 36343358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.
    Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A
    Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ustur Case 0846: Modeling Americium Biokinetics after Intensive Decorporation Therapy.
    Breustedt B; Avtandilashvili M; McComish SL; Tolmachev SY
    Health Phys; 2019 Aug; 117(2):168-178. PubMed ID: 30489383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decorporation of systemically distributed americium by a novel orally administered diethylenetriaminepentaacetic acid (DTPA) formulation in beagle dogs.
    Wilson JP; Cobb RR; Dungan NW; Matthews LL; Eppler B; Aiello KV; Curtis S; Boger T; Guilmette RA; Weber W; Doyle-Eisele M; Talton JD
    Health Phys; 2015 Mar; 108(3):308-18. PubMed ID: 25627942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the antidote requirements and outcomes of different radionuclide decorporation strategies for a scenario of a "dirty bomb" attack.
    Rump A; Stricklin D; Lamkowski A; Eder S; Abend M; Port M
    Am J Disaster Med; 2017; 12(4):227-241. PubMed ID: 29468625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of orally available, amphipathic polyaminocarboxylic acid chelators for actinide decorporation.
    Miller SC; Wang X; Bowman BM
    Health Phys; 2010 Sep; 99(3):408-12. PubMed ID: 20699705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally administered DTPA di-ethyl ester for decorporation of (241)Am in dogs: Assessment of safety and efficacy in an inhalation-contamination model.
    Huckle JE; Sadgrove MP; Pacyniak E; Leed MG; Weber WM; Doyle-Eisele M; Guilmette RA; Agha BJ; Susick RL; Mumper RJ; Jay M
    Int J Radiat Biol; 2015 Jul; 91(7):568-75. PubMed ID: 25912343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of cesium binding to ferric hexacyanoferrate: Prussian blue.
    Faustino PJ; Yang Y; Progar JJ; Brownell CR; Sadrieh N; May JC; Leutzinger E; Place DA; Duffy EP; Houn F; Loewke SA; Mecozzi VJ; Ellison CD; Khan MA; Hussain AS; Lyon RC
    J Pharm Biomed Anal; 2008 May; 47(1):114-25. PubMed ID: 18242038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decorporation of Pu and Am from beagles with delayed daily injections of 3,4,3-LICAM(C) or Zn-DTPA.
    Mays CW; Lloyd RD; Jones CW; Bruenger FW; Taylor GN; Durbin PW; White D; Raymond KN
    Health Phys; 1986 Apr; 50(4):530-4. PubMed ID: 3754241
    [No Abstract]   [Full Text] [Related]  

  • 20. [Decorporation agents for internal radioactive contamination].
    Ohmachi Y
    Yakugaku Zasshi; 2015; 135(4):557-63. PubMed ID: 25832835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.